The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Novel Food Application

6 Apr 2021 07:00

RNS Number : 4600U
Zoetic International PLC
06 April 2021
 

For immediate release

6 April 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

Zoetic International plc

('Zoetic', the 'Company' or the 'Group')

 

Zoetic's Novel Food Application passes FSA administrative check

 

Zoetic, the international CBD group, is pleased to provide the following update on its efforts to gain regulatory approval by the UK Food Standards Agency ('FSA' or the 'Agency') for its products in the United Kingdom. This FSA approval is now required for CBD products to be sold in the UK. This applies to all CBD brands and not only those owned by Zoetic.

 

Overview

· The FSA announced on 13 February 2020 that businesses must submit a novel food authorisation application by 31 March 2021 if they wish to have their CBD products sold in the UK. CBD products without the authorisation and subsequent validation would not be allowed to be sold in the UK.

 

· Zoetic submitted an application in conjunction with the European Industrial Hemp Association's ('EIHA') Novel Food Consortium.

 

· Zoetic received notification from EIHA that its CBD products passed the regulator's administrative check and can remain on sale in the UK.

 

· Official validation will be granted pending the results of toxicological studies on CBD, expected in the coming months.

 

Following the submission of a legal dossier, made in partnership with the EIHA's Novel Food Consortium, the Group has now received confirmation that its natural isolate CBD products can continue to be sold in the UK as the application has passed the regulator's administrative check. Official validation is expected to follow in the coming months, pending the results of toxicological studies of the CBD contained in its products.

 

Trevor Taylor, Co-CEO of Zoetic, said: "The FSA's regulation marks a pivotal moment for the CBD industry and Zoetic welcomes the Agency's efforts to protect consumers from CBD products that do not meet the necessary standards. We submitted our application with EIHA, a highly respected European industry association, and are thrilled that the submission has passed the initial check and we are now one step closer to full validation. As always, we are committed to rigorous quality assurance processes at every step because our success as a company is indivisible from the quality of our products."

 

Further progress is expected in the coming months. More information can be found on the EIHA website.

 

- Ends -

 

About the European Industrial Hemp Association

The European Industrial Hemp Association ('EIHA') represents the collective interests of key stakeholders in the hemp industry across the European Union ('EU'). Their primary function is to advocate for the industry by contributing to international policy-making consultations and decisions by European regulators. EIHA also operates a Novel Food Consortium which aims to secure the necessary regulatory approvals for members to continue producing and selling their products.

 

Publication on website

 

A copy of this announcement is also available on the Group's website at www.zoeticinternational.com

 

Media enquiries:

Zoetic International plc

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

 

Nick Naylor (Corporate Finance)

 

Guy McDougall (Equity Sales)

 

 

 

Buchanan

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000

zoetic@buchanan.uk.com

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKPBDDBKBKQK
Date   Source Headline
22nd Jun 20179:00 amRNSPrice Monitoring Extension
21st Jun 20177:30 amRNSFinal Results
21st Jun 20177:00 amRNSHighlands' First DT Ultravert Patent Issued
3rd May 201710:00 amRNSIssue of Shares
10th Apr 20177:00 amRNSApproval of Permit; Update on East Denver Drilling
20th Mar 20178:30 amRNSHolding(s) in Company
20th Mar 20178:25 amRNSIssue of Shares
10th Mar 20177:00 amRNSExpanded Renegade Agreement, East Denver
26th Jan 20174:30 pmRNSDefinitive Helios Two Gas Analysis Results
9th Jan 20177:00 amRNSIndependent analyses of core projects
19th Dec 20167:00 amRNSExtension of East Denver Farm-in Agreement
16th Dec 20167:00 amRNSFurther Farm-in Agreement In East Denver Project
24th Nov 20167:00 amRNSInterim Results
28th Oct 20167:00 amRNSHelios Two Drilling and Development Update
26th Oct 20167:00 amRNSExecutes Re-Fracking Agreement for DT Ultravert
20th Oct 20162:05 pmRNSHolding(s) in Company
20th Oct 20162:05 pmRNSHolding(s) in Company
20th Oct 20162:00 pmRNSIssue of Shares
19th Oct 20167:00 amRNSDT Ultravert Testing Update
30th Sep 20162:45 pmRNSDisposal of Warrants
30th Sep 20167:00 amRNSFirst Helios Two Well Drilled and Completed
30th Sep 20167:00 amRNSSchlumberger DT Ultravert Agreement Update
21st Sep 201611:10 amRNSIssue of Shares
20th Sep 20162:00 pmRNSResult of AGM
20th Sep 20167:00 amRNSOperations Update
19th Sep 20167:00 amRNSCommences Drilling at Helios Two, Montana
16th Sep 20167:00 amRNSHoldings in Company
16th Sep 20167:00 amRNSHoldings in Company
16th Sep 20167:00 amRNSIssue of Shares
2nd Sep 20164:55 pmRNSHoldings in Company
2nd Sep 20164:45 pmRNSIssue of Shares and Disposal of Warrants
17th Aug 20167:00 amRNSHelios Two Leasing and Development Update
11th Aug 20167:00 amRNSNotice of AGM
28th Jul 20167:00 amRNSExercise of Warrants
25th Jul 20167:00 amRNSDenver Julesburg Basin Farm-In Agreement
18th Jul 20167:00 amRNSHelios Two Leasing and Development Update
11th Jul 20169:05 amRNSSecond Price Monitoring Extn
11th Jul 20169:00 amRNSPrice Monitoring Extension
11th Jul 20167:00 amRNSUpdate on the Helios Two Transaction
11th Jul 20167:00 amRNSStatement re Termination of Agreement
8th Jul 20167:00 amRNSIssue of Shares
1st Jul 20167:00 amRNSIssue of Shares
28th Jun 20167:00 amRNSIssue of Shares
27th Jun 20163:30 pmRNSUpdated Corporate Presentation
27th Jun 20167:00 amRNSHelios Two: Receipt of Competent Persons Report
22nd Jun 20167:00 amRNSIssue of Shares
21st Jun 20162:05 pmRNSSecond Price Monitoring Extn
21st Jun 20162:00 pmRNSPrice Monitoring Extension
17th Jun 20167:00 amRNSUpdate on Disposal of Warrants
15th Jun 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.